Research.Patient.info
Focal Segmental Glomerulosclerosis research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
This study is looking at a new medicine called sparsentan for children aged 1 to 17 with certain kidney conditions like FSGS, MCD, IgAN, IgAV, and Alport Syndrome. It will check if the medicine is safe, works well, and how the body handles it over two years.
United States · Germany · Italy - recruitingPHASE2
Study of WAL0921 in Patients With Glomerular Kidney Diseases
This study is testing a new medicine, WAL0921, for people with certain kidney conditions, like diabetic kidney disease or rare kidney problems. It aims to see if the medicine is safe and effective in helping your kidneys. Some people will get the medicine, and others a dummy treatment.
United States · Australia · India